- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03042663
Effect of Stellate Ganglion Block on Blood Flow in the Cannulated Radial Artery
Effect of Stellate Ganglion Block on Blood Flow in the Cannulated Radial Artery in Septic Shock Patients on Vasopressors, A Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Radial artery cannulation is a well-established procedure in the ICU, especially in critically ill hemodynamically unstable patients. The first description of arterial cannulation in humans dates back to 1856, when the blood pressure was measured int the femoral artery. It can be used for continuous blood pressure monitoring, obtaining func¬tional hemodynamic parameters derived from the arterial waveform, to predict the physiologic response to fluid resuscitation and also for blood sampling.
The most common complications for the procedure are temporary radial artery occlusion (19.7%), in addition to hematoma (14.4%), infection at the arterial site (0.72%), hemorrhage (0.53%) or bacteremia (0.13%), pseudoaneurysm (0.09%) and finally ischemic damage (0.09%). Larger catheter diameter, presence of vasospasm, female sex (probably related to smaller vessel diameter) increase the risk of ischemic complications. Inadequate experience (high number of attempts, multiple arterial sticks and hematoma formation) can also increase the complication rate.
In a recent study by Numaguchi et al, they found that radial artery cannulation decreases the distal arterial blood flow measured by power Doppler ultrasound. In another study by Kim et al, they found that after radial artery cannulation ulnar artery diameters were significantly increased (compensatory) and radial artery diameters were decreased after cannulation compared with pre-cannulation values, then returned to pre-cannulation values 5 min after cannulation. They detected radial artery vasospasm in 12 patients with 20-G cannulas used (31.5%) and in 2 patients with 22-G cannulas used (5.3%) (p < 0.05), which was observed immediately after cannulation, and had mostly disappeared after 5 min. There was no data regarding the follow up of the patients afterwards. In both studies the subjects were not critically ill patients (and not on vasopressors).
Peripheral limb ischemia in ICU patients can be the result of iatrogenic injury, thrombotic complications or hypoperfusion related to the underlying disease state. The patients at greatest risk for acute ischemia are those with underlying peripheral artery disease (PAD), but limb ischemia can also be the consequence of embolism, injury, dissection, or severe vasoconstriction, even in the absence of preexisting occlusive disease. Repeated arterial punctures may result in extensive hematoma formation and arterial spasm, The thick muscular coat and abundance of alpha adrenoreceptors make it prone to develop spasm when traumatized. Attempts to control bleeding following cannulation through local hemostasis only complicate matters. While, normally, the likelihood of serious ischemia is minimized by the presence of the palmar arterial arch.
The use of vasopressors especially nor-epinephrine with its potent α1-adrenergic receptor agonist activity can aggravate the condition more. We didn't find in the literature any reliable data regarding the effect of using vasopressors (particularly nor-epinephrine) in any dosage on the incidence of peripheral arterial vasospasm or ischemic complications following arterial cannulation. But there were mixed case reports linking both or one of them: high dose vasopressors and arterial cannulation, to ischemic complications. Such as developing peripheral gangrene after starting high dose vasopressors, or developing complex regional pain syndrome (CRPS) following radial artery cannulation.
It is believed that blocking the Stellate ganglion with Local anesthetics can interfere with the sympathetic out flow to the upper limb resulting in abolishing its vasoconstrictor action on the arteries thus decreasing arterial spasm and promoting better blood flow in the peripheral circulation.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Eslam A Shawki, M.D.
- Phone Number: +201225771017
- Email: eslam.ayman@kasralainy.edu.eg
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Faculty of medicine, Cairo University teaching hospitals (Kasr Alainy)
-
Contact:
- Eslam A Shawki, M.D
- Phone Number: '+201225771017
- Email: eslam.ayman@kasralainy.edu.eg
-
Principal Investigator:
- Shereen M Amin, M,D
-
Sub-Investigator:
- Ahmed Z Fouad, M.D
-
Sub-Investigator:
- Ahmed S Abd El-Hameed
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age range of 18-80 years.
- Septic shock patients on vasopressor support (Nor-epinephrine or epinephrine).
- Presence of an indication for an arterial cannula.
Exclusion Criteria:
- Coagulopathies (with prothrombin concentration less than 60% or international normalized ratio INR more than 1.5)
- In-ability to postpone anti-coagulation medications.
- Infection or injury or a lesion at the block site.
- Suspected cervical vertebral column injury necessitating using a neck collar.
- Bradycardia with heart rate less than 60 beat per minute.
- A compromised lung on the contralateral side of the arterial cannula (Pneumothorax, hemothorax or Pneumonectomy).
- Recent cardiac insult (cardiogenic shock) (Due to blockage of the sympathetic cardiac accelerator fibers by the block).
- Traumatic vascular injuries or operative interventions (Surgical harvesting) involving arteries of the upper limb on either side.
- Peripheral vascular disease, atherosclerosis, atrial fibrillation, previous history of ischemic injuries, hypercoagulable syndromes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
In patients meeting the inclusion criteria and with absence of any exclusion criteria, and after taking PI and Doppler Blood flow values hourly for 3 hours (control values), the procedure for administering the USG Stellate ganglion block on the side of the arterial cannula will be started
|
After verification of proper needle position and aspiration to exclude vascular spread, 1mL of the injectate will be injected to see proper tissue spread as well as patient response.
After one minute the remaining volume will be injected under real time ultrasound imaging.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in Perfusion Index (PI)
Time Frame: After 30 minutes then every hour for 6 hours
|
change in Perfusion Index (PI) in the cannulated limb before and after the Stellate ganglion block.
|
After 30 minutes then every hour for 6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perfusion Index (PI) after cannulation
Time Frame: 3 hours
|
Perfusion Index (PI) values bilaterally after radial arterial cannulation
|
3 hours
|
Perfusion Index (PI) after Stellate ganglion block
Time Frame: 6 hours
|
Perfusion Index (PI) values bilaterally after Stellate ganglion block in the cannulated side.
|
6 hours
|
Doppler Blood flow values after cannulation
Time Frame: 3 hours
|
Doppler Blood flow values in the both Radial arteries after cannulation of one of them.
|
3 hours
|
Doppler Blood flow after Stellate ganglion block
Time Frame: 6 hours
|
Doppler Blood flow values in the both Radial arteries after Stellate ganglion block in the cannulated side.
|
6 hours
|
Vasopressor drug dose
Time Frame: 6 hours
|
Doses of vasopressor drugs used.
|
6 hours
|
Incidence of complications
Time Frame: 6 hours
|
Incidence of complications related to the Stellate ganglion block (Hematoma, Intravascular injection, Intrathecal injection, pneumothorax).
|
6 hours
|
Incidence of ischemic complications
Time Frame: 6 hours
|
Incidence of ischemic complications related to the arterial cannula (Unilateral) or Vasopressors and general condition of the patient (Bilateral) (changes in the form of either color changes or definite gangrene).
|
6 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009 Sep;37(9):2642-7. doi: 10.1097/CCM.0b013e3181a590da.
- Gershengorn HB, Garland A, Kramer A, Scales DC, Rubenfeld G, Wunsch H. Variation of arterial and central venous catheter use in United States intensive care units. Anesthesiology. 2014 Mar;120(3):650-64. doi: 10.1097/ALN.0000000000000008.
- Scheer B, Perel A, Pfeiffer UJ. Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care. 2002 Jun;6(3):199-204. doi: 10.1186/cc1489. Epub 2002 Apr 18.
- Glockner E, Harych H. [Guidelines for planning concerning physicians and stomatologists up to 1980]. Z Gesamte Hyg. 1970 Oct;16(10):811-22. No abstract available. German.
- Kim SY, Lee JS, Kim WO, Sun JM, Kwon MK, Kil HK. Evaluation of radial and ulnar blood flow after radial artery cannulation with 20- and 22-gauge cannulae using duplex Doppler ultrasound. Anaesthesia. 2012 Oct;67(10):1138-45. doi: 10.1111/j.1365-2044.2012.07235.x. Epub 2012 Jul 16.
- Lazaro RP. Complex regional pain syndrome and acute carpal tunnel syndrome following radial artery cannulation: a neurological perspective and review of the literature. Medicine (Baltimore). 2015 Jan;94(3):e422. doi: 10.1097/MD.0000000000000422.
- Rasmy I, Mohamed H, Nabil N, Abdalah S, Hasanin A, Eladawy A, Ahmed M, Mukhtar A. Evaluation of Perfusion Index as a Predictor of Vasopressor Requirement in Patients with Severe Sepsis. Shock. 2015 Dec;44(6):554-9. doi: 10.1097/SHK.0000000000000481.
- Yamazaki H, Nishiyama J, Suzuki T. Use of perfusion index from pulse oximetry to determine efficacy of stellate ganglion block. Local Reg Anesth. 2012;5:9-14. doi: 10.2147/LRA.S30257. Epub 2012 Mar 13.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- START
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stellate Ganglion Block
-
Zhonghua Chen,MDShaoxing Hospital of Zhejiang UniversityActive, not recruitingPossible Molecular Mechanism of Left Stellate Ganglion Block | Left Stellate Ganglion Block Can Quickly Restore the Left Stellate GanglionChina
-
Zhonghua Chen,MDChina (Zhejiang) Health technology RESEARCH and development and transformation...RecruitingLeft Stellate Ganglion Block on Rapid Recovery | Possible Molecular Mechanism of Left Stellate Ganglion BlockChina
-
The Affiliated Hospital of Xuzhou Medical UniversityUnknown
-
Rijnstate HospitalCompletedStellate Ganglion Block | Postmenopausal | Hot Flushes | Hot FlashNetherlands
-
Yangzhou UniversityCompleted
-
Mina sobhi said famRecruiting
-
Yangzhou UniversityRecruitingStellate Ganglion BlockChina
-
Yangzhou UniversityCompleted
-
Assiut UniversityUnknownIntubation | Stellate GanglionEgypt
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingPostoperative Nausea and Vomiting | Stellate Ganglion Block | Thyroid SurgeryChina
Clinical Trials on USG stellate ganglion block
-
University of PennsylvaniaRecruitingVentricular TachycardiaUnited States
-
West Virginia UniversityCompletedCOVID-19 | Acute Respiratory Distress SyndromeUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
Institute for Clinical and Experimental MedicineRecruitingVentricular Fibrillation | Ventricular Tachycardia | Ventricular Arrythmia | Block | Arrhythmic StormCzechia
-
Tanta UniversityMohamad Gamal Elmawy, M.DRecruiting
-
Aswan UniversityRecruitingHemodialysis | Arteriovenous Fistula | Stellate Ganglion Block | Major Lower Limb Orthopedic SurgeryEgypt
-
Beijing Tiantan HospitalRecruitingAneurysmal Subarachnoid Hemorrhage | Stellate Ganglion Block | Cerebral VasospasmChina
-
VA Office of Research and DevelopmentAnalydata, IncRecruiting
-
Beijing Tiantan HospitalNot yet recruitingSubarachnoid Hemorrhage, Aneurysmal | Cerebral Vasospasm
-
Rijnstate HospitalCompletedStellate Ganglion Block | Postmenopausal | Hot Flushes | Hot FlashNetherlands